(Q46657566)

24 December 2017

title

Effects of silymarin on the resolution of liver fibrosis induced by carbon tetrachloride in rats (English)

1 reference

24 December 2017

author name string

J H Tsai

1

1 reference

24 December 2017

J Y Liu

2

1 reference

24 December 2017

T T Wu

3

1 reference

24 December 2017

P C Ho

4

1 reference

24 December 2017

C Y Huang

5

1 reference

24 December 2017

J C Shyu

6

1 reference

24 December 2017

Y S Hsieh

7

1 reference

24 December 2017

C C Tsai

8

1 reference

24 December 2017

Y C Liu

9

1 reference

24 December 2017

publication date

4 April 2008

1 reference

24 December 2017

Journal of Viral Hepatitis

published in

1 reference

24 December 2017

volume

15

1 reference

24 December 2017

issue

7

1 reference

24 December 2017

page(s)

508-514

1 reference

24 December 2017

Liver fibrosis and chronic viral hepatitis.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00971.X

Hepatitis B virus-related cirrhosis: natural history and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00971.X

Seminars in medicine of the Beth Israel Hospital, Boston. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00971.X

Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00971.X

Long-term follow-up study of sustained biochemical responders with interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00971.X

Silymarin treatment of viral hepatitis: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00971.X

Randomized controlled trial of silymarin treatment in patients with cirrhosis of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00971.X

Resolution of liver fibrosis in chronic CCl4 administration in the rat after discontinuation of treatment: effect of silymarin, silibinin, colchicine and trimethylcolchicinic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00971.X

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00971.X

Alpha-SMA expression in hepatic stellate cells and quantitative analysis of hepatic fibrosis in cirrhosis and in recurrent chronic hepatitis after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00971.X

Hepatocellular carcinoma: the high-risk patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00971.X

Current strategies for chemoprevention of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00971.X

Lamivudine treatment in patients with chronic hepatitis B and cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00971.X

Regression of liver fibrosis in cases of chronic liver disease type C: quantitative evaluation by using computed image analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00971.X

Management of chronic hepatitis C virus infection: a new era of disease control

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00971.X

Regression of liver fibrosis after biliary drainage in patients with chronic pancreatitis and stenosis of the common bile duct

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00971.X

Reversibility of cirrhosis in patients cured of thalassemia by bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00971.X

Cirrhosis: new research provides a basis for rational and targeted treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00971.X

Tissue distribution of silibinin, the major active constituent of silymarin, in mice and its association with enhancement of phase II enzymes: implications in cancer chemoprevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00971.X

Antifibrotic effects of a tissue inhibitor of metalloproteinase-1 antibody on established liver fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00971.X

Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2893.2008.00971.X

10.1111/J.1365-2893.2008.00971.X

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017